When.com Web Search

  1. Ads

    related to: tumor marker ca15-3

Search results

  1. Results From The WOW.Com Content Network
  2. CA 15-3 - Wikipedia

    en.wikipedia.org/wiki/CA_15-3

    CA 15-3, for Carcinoma Antigen 15-3, is a tumor marker for many types of cancer, most notably breast cancer. [1] [2] [3] It is derived from MUC1. [4] CA 15-3 and associated CA 27-29 are different epitopes on the same protein antigen product of the breast cancer-associated MUC1 gene. Elevated CA15-3, in conjunction with alkaline phosphatase (ALP ...

  3. Tumor marker - Wikipedia

    en.wikipedia.org/wiki/Tumor_marker

    A tumor marker is a biomarker that can be used to indicate the presence of cancer or the behavior of cancers ... CA15-3: breast cancer [9] CA27.29: breast cancer [10]

  4. Mucin short variant S1 - Wikipedia

    en.wikipedia.org/wiki/Mucin_short_variant_S1

    CA 27.29 (aka BR 27.29) and CA 15-3 measure different epitopes of the same protein antigen product of the MUC1 gene seen in breast cancer. CA 27.29 has enhanced sensitivity and specificity compared to CA 15-3 and is elevated in 30% of patients with low-stage disease and 60 to 70% of patients with advanced-stage breast cancer.

  5. Category:Tumor markers - Wikipedia

    en.wikipedia.org/wiki/Category:Tumor_markers

    Pages in category "Tumor markers" The following 45 pages are in this category, out of 45 total. ... CA 15-3; CA 27-29; CA 242 (tumor marker) CA19-9; Calcitonin;

  6. Carcinoembryonic antigen - Wikipedia

    en.wikipedia.org/wiki/Carcinoembryonic_antigen

    The CEA blood test is not reliable for diagnosing cancer or as a screening test for early detection of cancer. [8] Most types of cancer do not result in a high CEA level. [9] Serum from individuals with colorectal carcinoma often has higher levels of CEA than healthy individuals (above approximately 2.5ng/mL). [10]

  7. Cancer biomarker - Wikipedia

    en.wikipedia.org/wiki/Cancer_biomarker

    Genetic, [1] epigenetic, [2] proteomic, [3] glycomic, [4] and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. [5] Cancer is a disease that affects society at a world-wide level.